167 related articles for article (PubMed ID: 37461256)
1. Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis.
Sabir U; Gu HM; Zhang DW
Phytother Res; 2023 Nov; 37(11):4932-4962. PubMed ID: 37461256
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.
Shan L; Wang F; Zhai D; Meng X; Liu J; Lv X
Biomed Pharmacother; 2023 May; 161():114472. PubMed ID: 37002573
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 participates in the progression from liver injury to fibrosis.
Gieling RG; Wallace K; Han YP
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1324-31. PubMed ID: 19342509
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-1 decorated polymersomes, a surface-active extracellular matrix therapeutic, potentiates collagen degradation and attenuates early liver fibrosis.
Geervliet E; Moreno S; Baiamonte L; Booijink R; Boye S; Wang P; Voit B; Lederer A; Appelhans D; Bansal R
J Control Release; 2021 Apr; 332():594-607. PubMed ID: 33737203
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase functions in hepatic injury and fibrosis.
Roderfeld M
Matrix Biol; 2018 Aug; 68-69():452-462. PubMed ID: 29221811
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix degradation and the role of hepatic stellate cells.
Benyon RC; Arthur MJ
Semin Liver Dis; 2001 Aug; 21(3):373-84. PubMed ID: 11586466
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases.
Geervliet E; Bansal R
Cells; 2020 May; 9(5):. PubMed ID: 32414178
[TBL] [Abstract][Full Text] [Related]
8. Effects of treatment with Maraviroc a CCR5 inhibitor on a human hepatic stellate cell line.
Coppola N; Perna A; Lucariello A; Martini S; Macera M; Carleo MA; Guerra G; Esposito V; De Luca A
J Cell Physiol; 2018 Aug; 233(8):6224-6231. PubMed ID: 29336497
[TBL] [Abstract][Full Text] [Related]
9. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis.
Calabro SR; Maczurek AE; Morgan AJ; Tu T; Wen VW; Yee C; Mridha A; Lee M; d'Avigdor W; Locarnini SA; McCaughan GW; Warner FJ; McLennan SV; Shackel NA
PLoS One; 2014; 9(7):e90571. PubMed ID: 25076423
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease.
Munsterman ID; Kendall TJ; Khelil N; Popa M; Lomme R; Drenth JPH; Tjwa ETTL
Histopathology; 2018 Oct; 73(4):612-621. PubMed ID: 29856896
[TBL] [Abstract][Full Text] [Related]
12. Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis.
Lachowski D; Cortes E; Rice A; Pinato D; Rombouts K; Del Rio Hernandez A
Sci Rep; 2019 May; 9(1):7299. PubMed ID: 31086224
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitors of metalloproteinases in liver fibrosis.
Iredale JP
Int J Biochem Cell Biol; 1997 Jan; 29(1):43-54. PubMed ID: 9076940
[TBL] [Abstract][Full Text] [Related]
14. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
Hu YB; Li DG; Lu HM
J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
[TBL] [Abstract][Full Text] [Related]
15. Emerging insights into the role of matrix metalloproteases as therapeutic targets in fibrosis.
Afratis NA; Selman M; Pardo A; Sagi I
Matrix Biol; 2018 Aug; 68-69():167-179. PubMed ID: 29428229
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-8 (MMP-8) regulates the activation of hepatic stellate cells (HSCs) through the ERK-mediated pathway.
Naim A; Baig MS
Mol Cell Biochem; 2020 Apr; 467(1-2):107-116. PubMed ID: 32108279
[TBL] [Abstract][Full Text] [Related]
17. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
Kim IS; Yang WS; Kim CH
Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.
Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G
Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221
[TBL] [Abstract][Full Text] [Related]
19. Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells.
Suárez-Cuenca JA; Chagoya de Sánchez V; Aranda-Fraustro A; Sánchez-Sevilla L; Martínez-Pérez L; Hernández-Muñoz R
Exp Biol Med (Maywood); 2008 Jul; 233(7):827-39. PubMed ID: 18445764
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Matrix Metalloproteinases by Plant-derived Products.
Anuar NNM; Zulkafali NIN; Ugusman A
Curr Cancer Drug Targets; 2021; 21(2):91-106. PubMed ID: 33222671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
